Free Trial

AIM ImmunoTech (AIM) Insider Trading & Ownership

AIM ImmunoTech logo
$0.20 +0.01 (+3.94%)
(As of 04:45 PM ET)

AIM ImmunoTech (NYSE:AIM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.02%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$155,461.29
Number Of
Insiders Selling
(Last 12 Months)
0
Get AIM Insider Trade Alerts

Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AIM Insider Buying and Selling by Quarter

AIM ImmunoTech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/18/2024Thomas K EquelsCEOBuy22,727$0.21$4,772.67  
12/2/2024Stewart AppelrouthDirectorBuy11,112$0.21$2,333.52  
11/20/2024Stewart AppelrouthDirectorBuy81,953$0.19$15,571.07  
11/20/2024Thomas K EquelsCEOBuy60,110$0.18$10,819.80  
9/16/2024Thomas K EquelsCEOBuy5,000$0.30$1,500.00  
5/6/2024Peter W Rodino IIICOOBuy30,865$0.41$12,654.65  
5/6/2024Thomas K EquelsCEOBuy61,729$0.41$25,308.89  
3/21/2024Nancy BryanDirectorBuy38,462$0.39$15,000.18  
3/15/2024Peter W Rodino IIICOOBuy37,879$0.33$12,500.07  
3/15/2024Stewart AppelrouthDirectorBuy90,910$0.33$30,000.30  
3/15/2024Thomas K EquelsCEOBuy75,758$0.33$25,000.14  
(Data available from 1/1/2013 forward)

AIM Insider Trading Activity - Frequently Asked Questions

The list of insiders at AIM ImmunoTech includes Nancy Bryan, Peter W Rodino III, Stewart Appelrouth, and Thomas K Equels. Learn more on insiders at AIM.

0.02% of AIM ImmunoTech stock is owned by insiders. Learn more on AIM's insider holdings.

The following insiders have purchased AIM shares in the last 24 months: Nancy Bryan ($15,000.18), Peter W Rodino III ($25,154.72), Stewart Appelrouth ($72,905.15), and Thomas K Equels ($162,323.80).

Insiders have purchased a total of 846,922 AIM shares in the last 24 months for a total of $275,383.85 bought.

AIM ImmunoTech Key Executives

  • Mr. Thomas K. Equels Esq.Mr. Thomas K. Equels Esq. (Age 71)
    J.D., M.S., Executive Vice Chairman, CEO & President
    Compensation: $953.19k
    3 recent trades
  • Mr. Robert Dickey IV (Age 68)
    M.B.A., Chief Financial Officer
    Compensation: $64.48k
  • Mr. Peter W. Rodino III (Age 73)
    Esq., J.D., COO, Executive Director of Governmental Relations, General Counsel & Secretary
    Compensation: $484.94k
  • Ann Marie E. Coverly
    Director of Administration & Human Resources and Deputy Investor Relations Coordinator
  • Dr. Carol A. Smith (Age 73)
    Chief Manufacturing Officer & Deputy Chief Scientific Officer
    Compensation: $170.77k
  • Dr. Christopher McAleer Ph.D.
    Scientific Officer
  • Dr. Ralph Christopher Cavalli Ph.D. (Age 66)
    Vice President of QC & Manufacturing
    Compensation: $234.79k


This page (NYSE:AIM) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners